Goldman Sachs Maintains Buy on Henry Schein

Goldman Sachs is out with its report today on Henry Schein (NASDAQ: HSIC), maintaining Buy.

In a note to clients, Goldman Sachs writes, "We hosted and Q&A session and investor dinner with Steven Paladino, EVP and CFO and Ferdinand Jahnel, VP and Treasurer where commentary on the company's key end-markets remains positive. Although timing remains fluid, the CFO was 'bullish' about an acceleration in demand of dental equipment."

Shares of HSIC closed Tuesday at $68.80.